James O. Armitage, Director at Cardiff Oncology, Inc. (CRDF), bought 4,000 shares at $10.82 ($43K) on 2021-03-19, disclosed to the SEC on 2021-05-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TSRO | SELL | 2017-09-20 | $2.3M | — | Filing → |
| TSRO | BUY | 2015-09-09 | $27K | — | Filing → |
| TSRO | BUY | 2014-12-15 | $38K | — | Filing → |